NATACYN

This brand name is authorized in Hong Kong, Singapore, United States

Active ingredients

The drug NATACYN contains one active pharmaceutical ingredient (API):

1 Natamycin UNII 8O0C852CPO - NATAMYCIN

Natamycin is a tetraene polyene antibiotic derived from Streptomyces natalensis. It possesses in vitro activity against a variety of yeast and filamentous fungi, including Candida, Aspergillus, Cephalosporium, Fusarium and Penicillium. The mechanism of action appears to be through binding of the molecule to the sterol moiety of the fungal cell membrane. Read about Natamycin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NATACYN Ophthalmic suspension, drops	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01AA10	Natamycin	S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AA Antibiotics
Discover more medicines within S01AA10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 41714
Country: SG	Health Sciences Authority	Identifier(s): 06719P
Country: US	FDA, National Drug Code	Identifier(s): 0065-0645